STM

Mark Lim, associate director of medical innovation at FasterCures and author of the study analyzed the characteristics of 369 consortia from around the world and found that these efforts provide a safe harbor for participants by guaranteeing transparency and equitable access to any outputs.
Read the release here

TRAINhomepageimage

FasterCuresupdated TRAIN Inventory is designed to help you better understand the landscape of nonprofit disease research foundations and engage in meaningful partnerships with them.

Check out the inventory

FCcommentssquare

"The decisions we make today will have implications long into the future. Now is the time to lean in and ensure everyone understands the NIH’s value proposition and relevance to patients and the economy, because it already takes too long to get from an idea to a treatment." - Margaret Anderson comments on the 21st Century Cures Initiative

BenefitRiskWebinar2

Join FasterCures for this FREE Webinar and hear how benefit-risk drives decision-making and emerging efforts to factor patients’ preferences into pharmaceutical product assessments

REGISTER HERE


Consortia-pedia

A quantitative and qualitative analysis of the emerging model of research-by-collaboration

Science Translational Medicine: Consortium Sandbox: Building and Sharing Resources

Press Release: Science Translational Medicine Focuses on Emergence of Consortia in Medical Research

Read the Report: Components and Characteristics of Consortia

Webinar: Consortia: Passing Fad or Industry Standard?